HIV-associated malignancies in children

AIDS Patient Care and STDs

Volumn 13, Issue 9, 1999, Pages 527-533

  Mueller, Brigitta U ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER INCIDENCE; CHILDHOOD CANCER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LEIOMYOSARCOMA; NONHODGKIN LYMPHOMA; SOFT TISSUE TUMOR; SUPERINFECTION;

EID: 0032840454     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1999.13.527     Document Type: Article

References (61)

1. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;43:1-12.
2. Robison LL. General principles of the epidemiology of childhood cancer. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven Publishers, 1997:1-10.
3. Centers for Disease Control and Prevention. US HIV and AIDS cases reported through December 1997. HIV/AIDS Surveillance report. Year-end edition 1997;9:1-44.
4. Granovsky MO, Mueller BU, Nicholson HS, Rosenberg PS, Rabkin CS. Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol 1998;16:1729-1735.
5. Pollock BH, Jenson HB, McClain KL, Leach CT, Joshi VV, Murphy SB. Risk factors for HIV-related malignancies in children. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:A17.
6. Evans JA, Gibb DM, Holland FJ, Tookey PA, Pritchard J, Ades AE. Malignancies in UK children with HIV infection acquired from mother to child transmission. Arch Dis Child 1997;76:330-333.
7. Buck BE, Scott GB, Valdes-Dapena M, Parks WP. Kaposi sarcoma in two infants with acquired immune deficiency syndrome. J Pediatr 1983;103:911-913.
8. Baum LG, Vinters HV. Lymphadenopathic Kaposi's sarcoma in a pediatric patient with acquired immune deficiency syndrome. Pediatr Pathol 1989;9:459-465.
9. Serraino D, Zaccarelli M, Franceschi S, Greco D. The epidemiology of AIDS-associated Kaposi's sarcoma in Italy. AIDS 1992;6:1015-1019.
10. Serraino D, Franceschi S. Kaposi's sarcoma and non-Hodgkin's lymphomas in children and adolescents with AIDS. AIDS 1996;10:643-647.
11. Centers for Disease Control and Prevention. AIDS among children-United States, 1996. MMWR 1996; 45:1005-1010.
12. Mbulaiteye SM, Ziegler JL, Katongole-Mbidde E, et al. Risk factors for childhood Kaposi's sarcoma in Uganda: A case control study. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:A18.
13. Ziegler JL, Katongole-Mbidde E. Kaposi's sarcoma in childhood: An analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 1996;65: 200-203.
14. Athale UH, Patil PS, Chintu C, Elem B. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:96-100.
15. Chintu C, Athale UH, Patil PS. Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child 1995;73:100-105.
16. Chadwick EG, Connor EJ, Guerra Hanson IC, et al. Tumors of smooth muscle origin in HIV-infected children. JAMA 1990;263:3182-3184.
17. McLoughlin LC, Nord KS, Joshi W, DiCarlo FJ, Kane MJ. Disseminated leiomyosarcoma in a child with acquired immune deficiency syndrome. Cancer 1991;67: 2618-2621.
18. Sabatino D, Martinez S, Young R, Balbi H, Ciminera P, Frieri M. Simultaneous pulmonary leiomyosarcoma and leiomyoma in pediatric HIV infection. Pediatr Hematol Oncol 1991;8:355-359.
19. Ross JS, Del Rosario A, Bui HX, Sonbati H, Solis O. Primary hepatic leiomyosarcoma in a child with the acquired immunodeficiency syndrome. Hum Pathol 1992;23:69-72.
20. Orlow SJ, Kamino H, Lawrence RL. Multiple subcutaneous leiomyosarcomas in an adolescent with AIDS. Am J Pediatr Hematol/Oncol 1992;14:265-268.
21. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995;332:12-18.
22. Kontny HU, Sleasman JW, Kingma DW, et al. Multilocular thymic cysts in children with human immunodeficiency virus infection. Clinical and pathological aspects. J Pediatr 1997;131:264-270.
23. Joshi VV. Systemic lymphoproliferative lesions in children with AIDS. Pediatr AIDS HIV Infect: Fetus to Adolesc 1990;1:44-48.
24. Soberman N, Leonidas JC, Berdon WE, et al. Parotid enlargement in children seropositive for human immunodeficiency virus: Imaging findings. Am J Radiol 1991;157:553-556.
25. Itescu S. Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: A model of rheumatic illness caused by acquired viral infection. Am J Immunol 1992;28:247-250.
26. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;41:1-19.
27. Magrath IT. Small noncleaved cell lymphomas (Burkitt's and Burkitt's-like lymphomas). In: Magrath I, ed. The non-Hodgkin's lymphomas. London: Arnold, 1997:781-811.
28. Shad A, Magrath IT. Malignant Non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven Publishers, 1997:545-588.
29. Isaacson PG. The MALT lymphoma concept updated. Ann Oncol 1995;6:319-320.
30. Slater DN. MALT and SALT: The clue to cutaneous B-cell lymphoproliferative disease. Br J Dermatol 1994;131:557-561.
31. Teruya-Feldstein J, Temeck BK, Sloas MM, et al. Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 1995;19:357-363.
32. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995;1:1274-1278.
33. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348: 858-861.
34. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996;10:175-180.
35. Koeller DM, Huang M-L, Chandran B, Vieitra J, Peipkorn M, Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunological correlates. J Infect Dis 1997;176:94-102.
36. Oksenhendler E, Cazals-Hatem D, Schulz TF, et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med 1998;338:1585-1590.
37. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996;10:1358-1362.
38. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86: 1276-1280.
39. Strauchen JA, Hauser AD, Burstein D, Jiminez R, Moore PS, Chang Y. Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med 1996;125:822-825.
40. Mouchet F, Ninane J, Gosseye S, et al. Leiomyoma of the suprarenal gland in a child with ataxia telangiectasia. Pediatr Hemat Oncol 1991;8:235-241.
41. Mueller BU, Butler KM, Feuerstein IM, et al. Smooth muscle tumors in children with human immunodeficiency virus infection. Pediatrics 1992;90:460-463.
42. Lee ES, Locker J, Nalesnik M, et al. The association of Epstein-Barr virus with smooth muscle tumors occurring after organ transplantation. N Engl J Med 1995;332:19-25.
43. Miser JS, Triche TJ, Kinsella TJ, Pritchard DJ. Other soft tissue sarcomas of childhood. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven Publishers, 1997:865-888.
44. Caussy D, Goedert JJ, Palefsky J, et al. Interaction of human immunodeficiency and papilloma viruses: Association with anal epithelial abnormality in homosexual men. Int J Cancer 1990;46:214-219.
45. Melbye M. Coté TR, Kessler L, Gail M, Biggar RJ, AIDS/Cancer Working Group. High incidence of anal cancer among AIDS patients. Lancet 1994;343:635-639.
46. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: An emerging problem. AIDS 1994;8:283-295.
47. Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Def Syndr 1990;3:896-903.
48. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993;71:402-406.
49. Roye CF. Abnormal cervical cytology in adolescents: A literature review. J Adolesc Health 1992;13:643-650.
50. Tweddel G, Heller P, Cunnane M, Multhaupt H, Roth K. The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol 1994;52:161-164.
51. Wright TC, Ellerbrock TV, Chiasson MA, van Devanter N, Sun X-W, The New York Cervical Disease Study. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-597.
52. Andrieu JM, Roithmann S, Tourani JM, et al. Hodgkin's disease during HIV1 infection: The French Registry experience. Ann Oncol 1993;4:635-641.
53. Errante D, Zagonel V, Vaccher E, et al. Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival. Ann Oncol 1994;5(suppl 2):S37-S40.
54. Levine A. HIV-associated Hodgkin's disease. Biologic and clinical aspects. Hematol Oncol Clin North Am 1996;10:1135-1148.
55. Tirelli U, Errante D, Dolcetti R, et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995;13:1758-1767.
56. Eyster ME, Diamondstone LS, Lien J-M, et al. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic 1993;6:602-610.
57. Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus in a high risk population. Pediatr Infect Dis J 1995;14: 195-199.
58. Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C and non-Hodgkin's lymphoma. Br J Haematol 1996;94:544-550.
59. Pontisso P, Morsica G, Ruvoletto MG, et al. Latent hepatitis B virus infection in childhood hepatocellular carcinoma. Analysis by polymerase chain reaction. Cancer 1992;69:2731-2735.
60. White YS, Johnson PJ, Davison F, Williams R. Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers. Br J Cancer 1990;61:909-912.
61. Olivero OA, Anderson LM, Diwan BA, et al. Transpla-cental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): Tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst 1997;89:1602-1608.